NEW YORK, NY – November 21, 2025 - Investors who purchased shares of Telix Pharmaceuticals Ltd. (TLX) are being alerted to a securities fraud class action lawsuit filed by The Rosen Law Firm, P.A. The firm is seeking to lead the litigation on behalf of investors who suffered losses.
The lawsuit alleges violations of federal securities laws. Investors who experienced financial losses on Telix Pharmaceuticals Ltd. securities between dates to be resolute are encouraged to contact the firm to discuss thier potential legal options. The case centers on allegations that Telix may have issued false or misleading statements to investors.
The Rosen Law Firm, P.A. is investigating potential claims and seeking to establish a lead plaintiff for the class action. Investors with notable losses are particularly encouraged to participate.
Investors can contact Laurence Rosen, Esq. or Phillip kim, Esq. at The Rosen Law Firm, P.A., 275 Madison Avenue, 40th Floor, New York, NY 10016. They can reach the firm via telephone at (212) 686-1060 or toll-free at (866) 767-3653. additional details is available via email at case@rosenlegal.com or on the firm’s website at www.rosenlegal.com.
Further details regarding the lawsuit can be found at: https://www.prnewswire.com/news-releases/tlx-investors-have-chance-to-lead-telix-pharmaceuticals-ltd-securities-fraud-lawsuit-filed-by-the-rosen-law-firm-302623539.html.
SOURCE THE ROSEN LAW FIRM,P. A.
